MESOBLAST
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes, and kidney disease, orthopedic spine conditions, and cardiovascular disorders.
MESOBLAST
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2004-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.mesoblast.com
Total Employee:
51+
Status:
Active
Contact:
(212) 880-2060
Email Addresses:
[email protected]
Total Funding:
412.3 M USD
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting IIS Cloudflare DNS
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-05-12 | Angioblast Systems | Angioblast Systems acquired by Mesoblast | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Mesoblast
Novaquest Capital Management
Novaquest Capital Management investment in Post-IPO Equity - Mesoblast
Australian Government for Research & Development
Australian Government for Research & Development investment in Post-IPO Equity - Mesoblast
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-04-09 | Osiris Therapeutics | Mesoblast investment in Post-IPO Equity - Osiris Therapeutics | 15 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-01 | Mesoblast Appoints Dr. Eric Rose as Chief Medical Officer |
Official Site Inspections
http://www.mesoblast.com Semrush global rank: 3.77 M Semrush visits lastest month: 3.58 K
- Host name: 104.19.220.104
- IP address: 104.19.220.104
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mesoblast"
Role and Composition of the Board - Mesoblast Ltd
Mesoblast - Wikipedia
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. See details»
Mesoblast - Crunchbase Company Profile & Funding
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including …See details»
Company - Mesoblast Ltd
Mesoblast has an extensive patent portfolio comprising approximately 1,000 patents and patent applications with protection extending through 2040 in all major markets. This intellectual property portfolio covers composition of …See details»
Mesoblast Limited (MESO) Company Profile & Facts - Yahoo Finance
See the company profile for Mesoblast Limited (MESO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Mesoblast Limited (ASX: MSB) Company Profile & Overview
3 days ago Mesoblast Company Description Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its …See details»
Mesoblast - Org Chart, Teams, Culture & Jobs - The Org
View Mesoblast's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Mesoblast - Contacts, Employees, Board Members, Advisors
Mesoblast has 10 current employee profiles, including Co-Founder, Chief Executive Officer and Managing Director Silviu Itescu. Silviu Itescu Co-Founder, Chief Executive Officer and …See details»
An Overview of Mesoblast Limited (MESO) - dcf-fm
In 2023, Mesoblast conducted an internal audit that revealed a 95% adherence rate to its compliance policies, demonstrating a commitment to maintaining high ethical standards across …See details»
Mesoblast Limited (MESO): history, ownership, mission, how it …
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Mesoblast Limited (MESO) Founding and Early Years Mesoblast Limited, founded in 2004, is …See details»
Global Leader in Allogeneic Cellular Medicines for ... - Mesoblast
May 26, 2023 Uncertainties and risks that may cause Mesoblast's actual results, performance or achievements to be materially different from those which may be expressed or implied by such …See details»
Mesoblast - Overview, News & Similar companies | ZoomInfo.com
Feb 29, 2024 Who is Mesoblast. Founded in 2004, Mesoblast, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. They offer products in the area s …See details»
Mesoblast - VentureRadar
" Mesoblast is a world leader in developing innovative allogeneic cellular medicines. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform …See details»
Contact Us - Mesoblast Ltd
Mesoblast Inc. W. R. Grace Building 1114 6th Avenue, 4th Floor New York, NY 10036. Mesoblast Limited. 55 Collins Street Level 38 Melbourne 3000. Mesoblast. ... The following is a link for …See details»
Unlocking the Potential of Mesoblast Ltd. (MESO): A Biotech Giant …
2 days ago One such company is Mesoblast Ltd., a biopharmaceutical firm that’s been making waves with its innovative mesenchymal lineage adult stem cell technology platform. A Brief …See details»
MESOBLAST COMPLETES US$110/A$138 MILLION FINANCING …
Mar 2, 2021 Mesoblast’s licensees, and the Company h as established commercial p artnerships in Europe and Chin a for certain Phase 3 assets. Mesoblast has locations in Australia, the …See details»
Third time lucky for Mesoblast | ApexOnco - Clinical Trials news …
Dec 19, 2024 After four years and two complete response letters, Mesoblast finally has FDA approval for its mesenchymal stem cell therapy Ryoncil (remestemcel-L) in paediatric steroid …See details»
Overview - Mesoblast Ltd
Mesoblast has an extensive patent portfolio comprising approximately 1,000 patents and patent applications with protection extending through 2040 in all major markets. This intellectual …See details»
Mesoblast Stock Rockets to New 52-Week High - Nasdaq
2 days ago Investors in biopharmaceutical company Mesoblast (MESO) are celebrating today as its shares are rocketing higher. The stock is trading for $21.09 as of this writing, marking a …See details»
Mesoblast After Approval: Stock Is Buoyant Now, But …
2 days ago Mesoblast is a non-US company, and these companies run on different metrics than US ones. They have existing revenue from various geographies, and they have non-dilutive …See details»